1 The types of pharmaceuticals include stimulants, antidepressants, narcotics and others.
2 For the new drug several phases of product development should proceed before market approval.
3 After preclinical and clinical testing product development may continue.
VI. .
1. 14.
2. Drug Product Development.
VII. .
.
.
- [ ]: / . . , . , . . - .: ; , 2011. - 358 .
- [ ]: / . . , . . . - 11- . - .: , 2011. - 384 .
- : / . . , . . . - 16- . - /: , 2014. - 316 .
- [ ]: . 1-2 , . 060108 ( ) / . . . , . . , . . [ .]; . - : , 2011. - 185 .
- [ ]: . "Hello, doctor!" / . . , . . , . . ; . - : , 2011. - 56 .
- - : / . . . [ .]. - .: -, 2013. - 496 .
[ ]: - 1 . / . .. , .. . - -: - . -, 2010. - 200 .
16
: ; -
: Drug Annotation
: -
I. .
1. .
2. - .
3. .
4. .
II.
- . . , .. , , , .
| ab-, apro-, de- | from, away | -, , |
| ad- | near, toward | -, , |
| ana- | up, apart, across | |
| ante-, pre-, pro | Before | -, - |
| circum-, peri- | Around | |
| co-, com-, sym-, syn- | with, together | -, -, |
| dia-, per-, trans- | Through | |
| dis-, de- | apart, from | -, -, -, , |
| super-, supra- | above | -, -, -, |
| em-, en-, im-, in- | In | -, |
| endo-, intra- | with | |
| ep- | upon | |
| re-, retro- | back | -, , |
| infra-, hypo-, sub- | under | -, |
| Inter | Between | , - |
| mono-, uni- | one | |
| bi-, di- | two | |
| ter-, try- | Three | |
| quadry-, tetra- | four | |
| cent- | hundred | |
| equi-, iso- | equal | |
| extra-, super-, hyper- | more, too many | , |
| hem-, sem- | half | |
| multi-, poly- | many | |
| a-, an- | without | -, -, , |
| anti-, contra- | against | -, -, - |
| un-, in-, im-, ir-, il- | not | -, - |
| andro- | man | |
| brady- | slow | |
| tachy- | fast | |
| cryo- | cold | |
| cyt- | cell | |
| gyn- | woman | |
| hydro- | water | |
| macro- | large | |
| micro- | small | |
| neo- | new | |
| pseudo- | false | |
| pyo- | pus |
|
|
|
